BioSpace News Archive

Business

Epigenomics AG Highlights Operational Achievements and Reports Financial Results for First Six Months 2019

Epigenomics AG announced the operational achievements plus financial results for the second quarter and the first half of 2019.

August 7, 2019

·

5 min read

Policy

Biomedical Startup Gears Up For U.S. Launch

Former Touch Bionics CEO joins Adapttech as company secures FDA decision for medical device that improves prosthesis fit

August 7, 2019

·

3 min read

Drug Development

Rhythm Pharma Reports Success in Two Late-Stage Trials for Genetic Obesity Disorders

Boston-based Rhythm announced positive topline data from two Phase III clinical trials of setmelanotide, its melanocortin-4 receptor (MC4R) agonist. The trials evaluated the drug for the treatment of pro-opiomelanocortin (POMC) and leptin receptor (LEPR) deficiency obesities.

August 7, 2019

·

2 min read

·

Mark Terry

“Biopsy Without a Knife": A New Cancer Imaging Technique

To identify tumors or to determine if they’re malignant, surgical biopsies or the use of imaging techniques that rely on contrast dyes, are most commonly used. Researchers have now developed a high-powered imaging technique that doesn’t use dyes.

August 7, 2019

·

2 min read

·

Mark Terry

Policy

FDA Says Some Preclinical Data was Manipulated for Novartis’ $2.1 Million Gene Therapy Drug

Despite the data concerns, the U.S. Food and Drug Administration said it believes the gene therapy should remain on the market. Novartis said it stands behind the safety and efficacy of the therapy.

August 7, 2019

·

3 min read

·

Alex Keown

Deals

Permira Snaps Up Cambrex in Deal Valued at $2.4 Billion

Permira initiated the transaction after Cambrex flexed its own M&A muscle and acquired Avista and Halo.

August 7, 2019

·

2 min read

·

Alex Keown

Business

Glauconix Biosciences Announces Appointment of Mrs. Kimberly Southern as Chief Operating Officer

Appointment reflects Glauconix Biosciences’ commitment to business and organizational excellence as they continue on their trajectory to become the leading developer of ex vivo-like 3D human tissue models for accelerating therapeutic innovation and drug discovery

August 7, 2019

·

4 min read

Policy

ISCT issues patient advice and concern on unproven T-cell preservation services

ISCT, the International Society for Cell and Gene Therapy announces its objection to linking the benefits of cellular immunotherapy, in particular Chimeric Antigen Receptor T-cell therapy, with recent market offerings for third party cryopreserving and banking of T-cells for future therapeutic use.

August 7, 2019

·

4 min read

Policy

Evox Therapeutics Granted Key Exosome Patents Covering RNA Therapeutics and Targeted Drug Delivery

Evox Therapeutics Ltd, a leading exosome therapeutics company, is pleased to announce that the Company has been granted three key patents by the United States Patent and Trademark Office and the European Patent Office.

August 7, 2019

·

2 min read

CStone to Build Global R&D Headquarters and Industrialization Base in the Suzhou Industrial Park

The signing ceremony for CStone Pharmaceuticals’ Global R&D Headquarters and Industrialization Base took place in Suzhou on August 6.

August 7, 2019

·

4 min read